IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025) for Risk Managers
What does IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025) require of a Risk Manager?
The IMDRF's ten guiding principles for good machine learning practice in medical devices: intended use and multi-disciplinary expertise, engineering and security fundamentals, representative and independent datasets, fit-for-purpose reference standards, suitable model design, human-AI team assessment, clinically relevant testing, clear user information, and post-deployment monitoring and re-training controls. Under IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025), which defines 10 controls, a Risk Manager's work is deciding which controls you own outright, which you share and which belong to another team, then holding the evidence for the first group.
Which IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025) controls land on the Risk Manager
Risk Managers identify, assess, and prioritise organisational risks. They build risk registers, conduct risk assessments, define risk appetite, and ensure that compliance frameworks address the most material threats to the organisation.
IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025) defines 10 controls across 1 domains that directly affect the Risk Manager role. Understanding which controls fall within your ownership, which are shared, and which are owned by other teams is the foundation of effective compliance management.
What a Risk Manager is accountable for under IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025)
Conducting enterprise risk assessments and maintaining the risk register
Defining risk appetite and tolerance levels with executive leadership
Mapping compliance controls to identified risks for coverage analysis
Monitoring key risk indicators (KRIs) and escalating emerging threats
Integrating compliance, operational, and strategic risk management
Where Risk Managers lose time on IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025)
These are the most common obstacles Risk Managers face when managing IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025) compliance, and how to address them:
Challenge 1
Quantifying cyber risk in financial terms that resonate with executives
Challenge 2
Identifying gaps between compliance control coverage and actual risk exposure
Challenge 3
Integrating risk data from siloed tools and departments
Challenge 4
Keeping risk assessments current as the threat landscape evolves
Challenge 5
Prioritising remediation when resources are limited
A working order for a Risk Manager starting on IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025)
1. Readiness Assessment
Take a 5-minute readiness assessment to identify your organisation's current gap profile against IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025). Get a prioritised action plan tailored to your specific situation.
2. Cross-Framework Mapping
Use our platform to map IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025) controls against other frameworks you already comply with. Identify overlapping controls to reduce duplicate effort.
3. Build Your Toolkit
Equip yourself with IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025) toolkits, self-assessments, and implementation guides from our store. Resources designed specifically for Risk Managers managing compliance programmes.
4. Continuous Monitoring
Establish ongoing compliance monitoring using our platform's gap analysis tools. Track your maturity over time and demonstrate progress to stakeholders.
IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025) in your sector
Who else owns part of IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025)
Questions Risk Managers ask about IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025)
What does a Risk Manager need to know about IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025)?
How does IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025) affect the Risk Manager role?
What are the biggest IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025) challenges for Risk Managers?
How should a Risk Manager prepare for a IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025) audit?
What tools help Risk Managers manage IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025) compliance?
Risk Manager: How ready is your organisation for IMDRF N88 Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025)?
Answer 25 questions and get a professional readiness report with gap analysis, maturity scores, and prioritised action items. Results in 5 minutes.